There is no official unified pricing standard for sunvozertinib at present, and the specific cost is to be determined comprehensively based on factors such as the patient's location, medical insurance policies, purchase channels and drug specifications. It is recommended to consult the latest price at formal medical institutions or pharmacies and take the medicine strictly as prescribed by a doctor.
Factors Affecting the Drug Price
Regional differences
Drug pricing may vary across provinces and cities, subject to local tendering and procurement policies.
Medical insurance reimbursement
Medical insurance or commercial insurance in some regions may cover part of the expenses, and you are advised to consult the local medical insurance department for details.
Specifications and treatment courses
The total cost will fluctuate with different drug specifications (e.g., 12.5mg, 25mg, etc.) and treatment regimens.
Purchase channels
Prices may differ between hospitals, pharmacies and online platforms; it is recommended to make purchases through formal channels.
Precautions for Medication
Indications and contraindications
The drug is indicated for specific cancer patients, but is contraindicated in those allergic to its ingredients and should be used with caution in patients with severe hypertension, hepatic insufficiency and other conditions.
Dosage adjustment
The dosage needs to be adjusted in light of adverse reactions (e.g., hypertension, hand-foot syndrome) or drug-drug interactions. For example, dosage adjustment should be made as prescribed by a doctor when the drug is used in combination with CYP3A4 inhibitors/inducers.
Adverse reaction management
Common adverse reactions include fatigue and diarrhea; in severe cases, hepatotoxicity or cardiac problems may occur. Regular monitoring and timely medical treatment are required.
Medical Guidance and Recommendations
Individualized treatment
A treatment plan shall be formulated by an oncology specialist after a comprehensive assessment of the patient's condition; the drug shall not be taken or the dosage adjusted without medical advice.
Regular follow-up
During the treatment period, regular reexaminations such as blood routine, liver function and electrocardiogram are required to monitor the therapeutic effect and safety of the drug.
Medical insurance and assistance
Some pharmaceutical companies offer patient assistance programs, and you may consult your attending physician or relevant public welfare organizations for information.
The pricing and medication plan of the drug shall be determined in combination with clinical practice, and treatment must be conducted under the guidance of professional physicians.
